Hg5ln gal4-hppar gamma cell line

HG5LN were generated by transfection of cervical cancer HeLa cells with the (GAL4RE)5-betaGlobin-Luciferase-SV40-Neomycin plasmid. HG5LN GAL4-hPPAR gamma cells were generated by transfection of HG5LN cells with the plasmid pSG5-GAL4-human PPAR gamma-puromycin. The plasmid (GAL4RE)5-betaGlob-Luc-SVNeo contains a luciferase gene driven by a pentamer of yeast activator GAL4 binding sites in front of beta-globin promoter and a neomycin phosphotransferase gene under the control of SV40 promoter. The pSG5-puro plasmid pSG5-human GAL4-hPPAR gamma-puromycin enables to express the DNA binding domain of the yeast activator GAL4 (GAL4 DBD) followed by the ligand binding domain of the human peroxisome proliferator activated receptor receptor gamma (hPPAR gamma LBD). Puromycin N-acetyl transferase selection marker expression confers resistance to puromycin.

Interest / Relevance: These cells enable to measure the hPPAR gamma (full and partial agonism, antagonism) of pharmaceuticals (metabolic diseases), environmental compounds (bisphenols).
These cells enable to measure the hPPAR gamma activity of environmental (water, sediments), human (blood, urine adipose tissue) or food (water, vegetables, meat) samples.
Rosiglitazone EC50 18 nM
Keywords: hPPAR gamma, luciferase, pharmaceutical and environmental chemicals
Scientist's name: Patrick BALAGUER
Patrick Balaguer



Business Developper
Inserm Transfert
Research Tools
Culture Medium: DMEM-F12, 5% FCS, 1% gentamycin, G418 1 mg/ml, pyuromycin 0,5 microgram/ml
Rare disease:
Last update: 05/06/2023

You might also be interested in


Inserm Transfert

Research tool licensing team